Targeted therapy for HER-2: personalized medicine for her, too

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F12%3A33140631" target="_blank" >RIV/61989592:15110/12:33140631 - isvavai.cz</a>

Result on the web

<a href="http://dx.doi.org/10.1515/CCLM.2011.724" target="_blank" >http://dx.doi.org/10.1515/CCLM.2011.724</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1515/CCLM.2011.724" target="_blank" >10.1515/CCLM.2011.724</a>

Result language

angličtina

Original language name

Targeted therapy for HER-2: personalized medicine for her, too

Original language description

In the past decade, it has been realized that rather than a single entity, breast cancer represents a spectrum of neoplastic disorders affecting the same organ (1-4). The expression of human epidermal growth factor receptor-2 (HER-2) is characteristic ofsubtype(s) of breast cancer with an unfavorable prognosis.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2012

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Clinical Chemistry and Laboratory Medicine

ISSN

1434-6621

e-ISSN

—

Volume of the periodical

50

Issue of the periodical within the volume

1

Country of publishing house

DE - GERMANY

Number of pages

4

Pages from-to

1-4

UT code for WoS article

—

EID of the result in the Scopus database

—